2026-01-28 - Analysis Report
**Company Overview**
Charles Schwab is a leading online brokerage firm that offers a wide range of financial services.

**Return Rate Comparison**

* Cumulative return of review stock (SCHW): 121.56%
* Cumulative return of comparison stock (S&P 500, VOO): 128.51%
* Divergence: -7.70 (current), 41.40% (relative divergence)

The review stock (SCHW) has performed better than the comparison stock (S&P 500, VOO) in terms of cumulative return.

**Alpha, Beta Analysis**

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2016-2018  | 10.0% | 25.1% | 1.0% | 1.5 | 75.4B |
| 2017-2019  | -18.0% | 25.1% | -43.0% | 1.3 | 86.3B |
| 2018-2020  | -15.0% | 41.8% | -39.0% | 1.1 | 96.3B |
| 2019-2021  | 83.0% | 41.8% | 19.0% | 1.1 | 152.7B |
| 2020-2022  | 74.0% | 40.2% | 69.0% | 1.1 | 151.1B |
| 2021-2023  | 19.0% | 43.2% | 1.0% | 1.1 | 124.9B |
| 2022-2024  | -51.0% | 43.2% | -80.0% | 1.0 | 134.3B |
| 2023-2025  | 35.0% | 39.8% | -41.0% | 0.9 | 181.4B |

The company's CAGR (Compound Annual Growth Rate) has been volatile over the years, ranging from -18.0% to 83.0%. The Alpha and Beta values indicate that the company's performance has been closely tied to the market.

**Recent Stock Price Fluctuations**

* Close: $103.72
* Last-market: $103.72 (increase of $0.78 from previous close)
* 5-day SMA: $102.94
* 20-day SMA: $102.07
* 60-day SMA: $97.32

The company's stock price has shown a recent increase, but the short-term moving averages are still below the current price.

**RSI, PPO Index Indicators and Delta_Previous_Relative_Divergence, Expected_Return**

* Market Risk Indicator (MRI): 0.70 (Medium investment)
* RSI: 50.42
* PPO: -0.13
* Recent relative divergence change: -1.90 (worsening)
* 7-day Rank change: 11 (rank up)
* 7-day Dynamic Expected Return change: 102.10 (improving)
* Expected Return (%): -24.80%

The company's market risk indicator suggests a medium investment risk, and the RSI and PPO values indicate a lack of volatility. However, the relative divergence has worsened recently, and the expected return is negative.

**Recent News & Significant Events**

* [2026-01-27] SCHW or HOOD: Which Is the Better Value Stock Right Now? - Yahoo Finance
* [2026-01-27] Why Charles Schwab just ranked best online broker for 2026 traders - Stock Titan
* [2026-01-26] Charles Schwab: Expect Higher Capital Returns In 2026 (NYSE:SCHW) - Seeking Alpha
* [2026-01-22] TD Cowen Forecasts Strong Price Appreciation for Charles Schwab (NYSE:SCHW) Stock - MarketBeat
* [2026-01-26] Charles Schwab (SCHW) Target Price Raised by Barclays to $126 | - GuruFocus
* [2026-01-25] Charles Schwab (SCHW) received an outperform rating from Citizens amid high consensus forecasts - MSN

These recent news articles suggest that the company is expected to perform well in 2026 and that its stock price may appreciate.

**Analyst Opinions**

Analyst Consensus:

* Key: Buy
* Mean (1=StrongBuy~5=Sell): 1.71 (~Buy)
* Opinions: 18
* Target Price (avg/high/low): 120.94 / 148.00 / 94.00

The analyst consensus suggests that the company is a buy, with a mean opinion of 1.71. The target price range is between $94.00 and $148.00.

**Recent Earnings Analysis**

| Date | EPS | Revenue |
|-----|----|--------|
| 2025-11-07 | 1.26 | 6.13 B$ |
| 2025-08-08 | 1.09 | 5.85 B$ |
| 2025-05-09 | 0.99 | 5.60 B$ |
| 2024-11-08 | 0.71 | 4.85 B$ |

The company's earnings per share (EPS) has increased since 2024, but revenue has remained relatively stable.

**Financial Information**

No 'Total Revenue' or 'Gross Profit' data available for SCHW.

**Comprehensive Analysis**

Based on the analysis above, the company's stock price has shown a recent increase, but the short-term moving averages are still below the current price. The market risk indicator suggests a medium investment risk, and the RSI and PPO values indicate a lack of volatility. However, the relative divergence has worsened recently, and the expected return is negative. The analyst consensus suggests that the company is a buy, and recent news articles suggest that the company is expected to perform well in 2026.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.